In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity
- 1 April 1996
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 5 (2) , 139-145
- https://doi.org/10.1177/096120339600500209
Abstract
Objective: to investigate the relationship between disease activity and in vitro cytokine, soluble(s)CD23 and polyclonal and anti-DNA antibody production by PBMC from patients with active systemic lupus erythematosus (SLE). Methods: cytokines, sCD23 and immunoglobulins were estimated by ELISA in unstimulated and polyclonal mitogen-stimulated culture supernatants. Results: PHA-induced IL-2 and IFN-y production were decreased, whereas spontaneous and PHA-induced IL-6 and IL-10 production were increased in cultures of SLE lympho cytes. Conversely, spontaneous and PHA-stimulated IL-4 and sCD23 production was com parable between patients and controls. Finally, we found an increase in in vitro spontaneous polyclonal and anti-DNA IgG secretion. Conclusions: We demonstrated an expanded type-2 cytokine profile with no correlation with parameters of disease activity.Keywords
This publication has 31 references indexed in Scilit:
- The Th1–Th2 hypothesis of HIV infection: new insightsImmunology Today, 1994
- Impaired Release of sCD23 by Activated B-Cells from RA PatientsClinical Immunology and Immunopathology, 1994
- Macrophage depletion decreases IgG anti-DNA in cultures from (NZB · NZW)F1 spleen cells by eliminating the main source of IL-6Clinical and Experimental Immunology, 1993
- A TH1→TH2 switch is a critical step in the etiology of HIV infectionImmunology Today, 1993
- Cytokine abnormalities in human lupusClinical Immunology and Immunopathology, 1992
- Cytokine secretion phenotypes of TH cells: how many subsets, how much regulation?Research in Immunology, 1991
- B cell lymphokines in human systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1989
- CD23: a multi-functional receptor/ lymphokine?Immunology Today, 1989
- In vivo immunopotentiating activity of thymopentin in aging humans: Modulation of IL-2 receptor expressionClinical Immunology and Immunopathology, 1988
- Immunomodulating activity of RU 41740: In vitro and in vivo studies on human lymphocytesInternational Journal of Immunopharmacology, 1987